Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.
Morrow
David A
DA
Department of Medicine and TIMI Study Group, Cardiovascular Division, Brigham & Women's Hospital, 75 Francis St., Boston, MA 02115, USA. dmorrow@partners.org
Rifai
Nader
N
Sabatine
Marc S
MS
Ayanian
Shake
S
Murphy
Sabina A
SA
de Lemos
James A
JA
Braunwald
Eugene
E
Cannon
Christopher P
CP
D000208:Acute Disease; D000409:Alanine / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007118:Immunoassay; D008297:Male; D008875:Middle Aged; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011759:Pyrrolidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013577:Syndrome; D019210:Troponin I / Q000097:blood*
D015415:Biomarkers; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011759:Pyrrolidines; D019210:Troponin I; C120234:orbofiban; D000409:Alanine